No Data
No Data
Bruker Corp: Strong Buy Recommendation on Market Leadership and Strategic Acquisitions
Cellens Announces Collaboration With Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection
Cellens, Inc., an early-stage cancer diagnostic company pioneering in applying mechanobiology and machine learning analysis today announced that it is collaborating with Bruker BioAFM, a business unit of Bruker
Nomura Holdings Inc. Makes New Investment in Bruker Co. (NASDAQ:BRKR)
Loss of 1.1 billion in 3 years! "China's Lego" rushes to the Hong Kong Stock Exchange, can Ultraman replicate the miracle of IPO?
Bruck wants to use the 'Ultraman' light to knock on the door of the capital markets.
Bruker's (NASDAQ:BRKR) 7.1% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
Declining Stock and Solid Fundamentals: Is The Market Wrong About Bruker Corporation (NASDAQ:BRKR)?
Bruker (NASDAQ:BRKR) has had a rough three months with its share price down 30%. However, a closer look at its sound financials might cause you to think again. Given that fundamentals usually drive
Mr Careful : I got burned before by following his trades.
102877280 : his is not God though lol
BrianjhOP Mr Careful: Remember to do your own due diligence. His advice is infamous for bad returns![undefined undefined](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
MultiBaggers : Do the opposite of what Michael Burry does
BrianjhOP MultiBaggers: exactly
View more comments...